Genotype 5 Japanese Encephalitis Virus—Old Genotype, New Threat
en-GBde-DEes-ESfr-FR

Genotype 5 Japanese Encephalitis Virus—Old Genotype, New Threat

05.08.2022 Compuscript Ltd

https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2022-0016
Announcing a new article publication for Zoonoses journal. Japanese encephalitis (JE) is an important viral encephalitis with epidemic status in Asia, which is caused by Japanese encephalitis virus (JEV), a member of the genusFlavivirus.
JEV is divided into five genotypes. Genotype 5 (G5) is relatively neglected because of the limited number of cases and strains isolated. The first strain of G5 JEV (Muar strain) was isolated in Singapore in 1952 in a patient from Muar, Malaysia. The second strain (XZ0934) was isolated 57 years later in China, thus indicating the re-emergence of G5 JEV. A female patient who had been vaccinated against JE was infected with G5 JEV in Korea in 2015. JE is a vaccine-preventable disease, and its incidence has decreased with vaccination in many Asian countries. G3 JEV is the main candidate for current JE vaccines, which include attenuated, inactivated and chimeric type vaccines. However, the available vaccines do not provide adequate protection against the older G5 JEV lineage.
More research on this genotype is crucial for developing better detection methods, expanding surveillance to determine the possible chains of viral transmission for this new threat and developing a polyvalent JEV vaccine.
Article reference: Weijia Zhang, Chongxiao Xu and Kai Nie et al. Genotype 5 Japanese Encephalitis Virus—Old Genotype, New Threat.Zoonoses.Vol. 2(1). DOI: 10.15212/ZOONOSES-2022-0016
Keywords: Japanese encephalitis virus (JEV), Japanese encephalitis (JE), genotype 5, vaccine
# # # # # #
Zoonoses is fully open access journal for research scientists, physicians, veterinarians, and public health professionals working on diverse disciplinaries of zoonotic diseases.

Zoonoses is now open for submissions; articles can be submitted online at https://mc04.manuscriptcentral.com/zoonoses

Please visit https://zoonoses-journal.org/ to learn more about the journal.
Editorial Board: https://zoonoses-journal.org/index.php/editorial-board/
# # # # # #
Zoonoses is available on ScienceOpen (https://www.scienceopen.com/search#collection/839df240-327f-47dd-b636-9b728dff9700).

Submissions may be made using ScholarOne (https://mc04.manuscriptcentral.com/zoonoses).
There are no author submission or article processing fees.

Follow Zoonoses on Twitter @ZoonosesJ; Facebook (https://www.facebook.com/Zoonoses-Journal-100462755574114 ) and LinkedIn (https://www.linkedin.com/company/zoonoses/)

eISSN 2737-7474
ISSN 2737-7466
# # # # # #
Weijia Zhang, Chongxiao Xu and Kai Nie et al. Genotype 5 Japanese Encephalitis Virus—Old Genotype, New Threat. Zoonoses. Vol. 2(1). DOI: 10.15212/ZOONOSES-2022-0016
05.08.2022 Compuscript Ltd
Regions: Europe, Ireland, Asia, China, Malaysia, Singapore
Keywords: Health, Medical

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2022 by DNN Corp Terms Of Use Privacy Statement